丝袜 中出 制服 人妻 美腿-性一交一无一伦一精一品-妺妺窝人体色WWW看美女-国产精品无码专区AV在线播放

您好!歡迎訪問上海易匯生物科技有限公司網站!
全國服務咨詢熱線:

18501609238

當前位置:首頁 > 產品中心 > Illumina > 二代測序 > 15032350illumina NXTR XT樣本制備試劑盒 *

illumina NXTR XT樣本制備試劑盒 *

簡要描述:品 牌: Illumina
產 地: 美國
NXTR XT樣本制備試劑盒(24樣本 第一盒)15032350
Nextera XT Library Prep kit 96 Samples(BOX 1of2) 15032354
NXTR XT標簽試劑盒V2(套件A 96標簽 192樣本)15052163
illumina NXTR XT樣本制備試劑盒 *

  • 產品型號:15032350
  • 廠商性質:生產廠家
  • 更新時間:2021-11-16
  • 訪  問  量:1625

詳細介紹

品牌illumina/美國因美納貨號15032350
規格供貨周期現貨
主要用途基因測序應用領域醫療衛生,化工,生物產業,制藥,綜合

illumina NXTR XT樣本制備試劑盒 *

illumina NXTR XT樣本制備試劑盒 *

微信圖片_20211104095403.jpg


illumina 15032350

illumina 15032350 NXTR XT樣本制備試劑盒

NXTR XT樣本制備試劑盒(24樣本 第一盒)


Nextera XT Library Prep kit 96 Samples(BOX 1of2) 15032354


NXTR XT標簽試劑盒V2(套件A 96標簽 192樣本)15052163


Next-Generation sequencing

Total RNA was extracted from each patient’s plasma sample, and cDNA synthesis followed. The QIAamp Viral RNA Mini Kit (Cat. #52904, Qiagen, Gaithersburg, MD) and the SuperScript?6?4 IV First-Strand Synthesis System (Cat. # 18091050, Invitrogen, Carlsbad, CA) were used respectively and according to manufacturers’ instructions. Multiple sets of HIV-1 specific primer pairs were used to target and amplify using polymerase-chain-reaction (PCR) the protease (PR), reverse transcriptase (RT), integrase (int), and envelope (env) HIV-1 genes (~43% of genome)36. Library preparation was completed with Nextera XT Library Prep (Cat. # 15032350, Illumina, Dan Diego, CA). Samples were then sequenced on eight runs on an Illumina MiSeq platform using the MiSeq v2 (300 cycles) chemistry (Cat. # MS-102–2002, Illumina). Both library prep and sequencing were completed according to the manufacturer’s instructions. All DNA sequence files are available from the GenBank database under SRA accession: PRJNA517147.


產品咨詢

留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7
上海易匯生物科技有限公司
地址:上海市奉賢區金大公路8218號1幢
郵箱:1006909781@qq.com
傳真:QQ1006909781
關注我們
歡迎您關注我們的微信公眾號了解更多信息:
歡迎您關注我們的微信公眾號
了解更多信息